Comments
Loading...

Y-mAbs Therapeutics

YMABNASDAQ
Logo brought to you by Benzinga Data
$8.15
0.040.49%
At close: -
$8.15
0.000.00%
After Hours: 1:00 PM EDT

Y-mAbs Therapeutics (NASDAQ:YMAB) Stock Quotes, Forecast and News Summary

Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
4
1
Aug
2
Sep
2
Nov
2
Dec
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$8.13
Close$8.15
Volume / Avg.150.23K / 248.69K
Day Range$7.80 - $8.23
52 Wk Range6.29 - 20.90
Market Cap$365.03M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
27
Short Interest
10.28%
Days to Cover16.55

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
YMAB
VALN

FAQ

Q

How do I buy Y-mAbs Therapeutics (YMAB) stock?

A

You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Y-mAbs Therapeutics (YMAB) competitors?

Q

What is the forecast, or price target, for Y-mAbs Therapeutics (YMAB) stock?

A

Y-mAbs Therapeutics has a consensus price target of $19.08.

Q

What is the current price for Y-mAbs Therapeutics (YMAB)?

A

The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $8.15 last updated December 24, 2024 at 1:00 PM EST.

Q

Does Y-mAbs Therapeutics (YMAB) pay a dividend?

A

There are no upcoming dividends for Y-mAbs Therapeutics.

Q

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

A

Y-mAbs Therapeutics’s Q4 earnings are confirmed for Thursday, February 27, 2025.

Q

Is Y-mAbs Therapeutics (YMAB) going to split?

A

There is no upcoming split for Y-mAbs Therapeutics.

Q

What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?

A

Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch